🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsMetabolic Health & DiabetesType 1.5 diabetes (LADA) and GLP-1 — what worked for you? Page 6

Type 1.5 diabetes (LADA) and GLP-1 — what worked for you?

pete_manc_UK Sun, Mar 16, 2025 at 5:43 AM 36 replies 2,172 viewsPage 6 of 8
RetaRick_CA
VIP Member
2,012
9,876
Jan 2024
California
Apr 2, 2025 at 7:13 PM#26
KevinCompounds said:
It is worth asking what the claim would look like if it were false.

Coming at KevinCompounds’s question from a different direction. Whatever the answer turns out to be, the method for getting there is the same: state the assumption, do the arithmetic in public, and invite the correction. That is slower than asserting, and it is the only version that survives being wrong.

8 6SkepticalSean, Dr.CardioMD, EndoResFellow and 5 others
Reply Quote Save Share Report
DanielChem_CHI
Senior Member
1,234
5,678
Mar 2024
Chicago, IL
Apr 4, 2025 at 11:47 PM#27

The figures, for anyone assembling their own picture. Give anything pharmacological four weeks before you judge it, and give anything measured weekly a four-point rolling average before you call it a trend.

9 7Dr.DermMIA, fiona_VT, denise_HTX and 6 others
Reply Quote Save Share Report
josh_phd_bmore
Member
389
1,678
Jul 2024
Baltimore, MD
Apr 7, 2025 at 4:23 AM#28

Following on from KevinCompounds — and this may be the naive question:

Was that from a primary source or from a summary of one?

Last edited: Apr 7, 2025 at 6:23 AM
10 8zoe_NC, Dr.ObesityLA, NurseKim_ATL and 7 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
Dr.SurgeonPGH
Senior Member
1,345
6,789
Mar 2024
Pittsburgh, PA
Apr 9, 2025 at 9:00 AM#29
DanielChem_CHI said:
Give anything pharmacological four weeks before you judge it, and give anything measured weekly a four-point rolling average before you call it a…

I am going to disagree with the direction of travel here. The thread has converged on the tidiest answer rather than the best-supported one, and those are not the same thing.

Last edited: Apr 9, 2025 at 12:00 PM
11 9RickReta_CO, PharmHunterJen, TomTeleRx and 8 others
Reply Quote Save Share Report
pete_manc_UK
Senior Member
1,234
5,678
Mar 2024
Manchester, UK
Apr 11, 2025 at 1:38 PM#30

Closing the loop on my own question.

Following up because I said I would. I changed one thing, left everything else alone, and waited the full interval before looking. It resolved, and I cannot prove which half of that did it.

33 6mike.trainer_LA, sarah_nash92, FitDadDave and 30 others
Reply Quote Save Share Report

Similar Threads

SUSTAIN-6 to SELECT — the cardiovascular evidence timeline14 replies
GLP-1 and insulin resistance — HOMA-IR improvement data17 replies
Metabolic syndrome reversal criteria — how GLP-1 addresses all 55 replies
A1C target achievement rates — sema vs tirz comparison8 replies
SURPASS-CVOT: tirzepatide cardiovascular outcomes trial design3 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register